Healthcare -
Biotechnology - NASDAQ - FR
$ 2.1264
0.302 %
$ 178 M
Market Cap
-4.83
P/E
IPHA - LONG-TERM INVESTMENTS
Long-term Investments IPHA - Innate Pharma S.A.
9.8 M
LAST VALUE
-50.44%
2 YEAR CAGR
-22.56%
5 YEAR CAGR
43.10%
10 YEAR CAGR